小分子胆化酶配体的光化学驱动的设计
Irena Škorić1, Maja Sviben1, Milena Mlakić1
1Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000, Zagreb, Croatia.
Chemico-biological interactions
|August 15, 2025
概括
研究人员探索了异环化合物作为神经退行性疾病和有机中毒的潜在治疗方法. 这些新型分子显示出作为乙胆酶 (AChE) 和丁胆酶 (BChE) 抑制剂和活性剂的前景.
科学领域:
- 神经药理学神经药理学
- 药用化学 医学化学
背景情况:
- 胆酶抑制剂对于治疗神经退行性疾病和有机酸盐中毒至关重要.
- 开发选择性和有效的胆酶抑制剂仍然是一个重大挑战.
研究的目的:
- 审查作为胆酶抑制剂和活性剂的异环化合物的合理设计,合成和生物分析.
- 探索在阿尔茨海默病中潜在的治疗应用和作为化学威胁对策的新型配体.
主要方法:
- 对多种异环基架的系统审查,包括氧,异乙烯,三和双环[3.2.1]氧/八二烯衍生物.
- 对乙胆酶 (AChE) 和丁胆酶 (BChE) 的抑制和重新激活概况的评估.
- 对有前途的化合物的选择性,抗氧化活性和中枢神经系统透性的评估.
主要成果:
- 新型氨基-氧化乙烯证明了选择性胆化酶 (BChE) 抑制.
- 纳夫托克萨和三醇支架显示双目标或BCHE选择性抑制.
- 某些氧化物有效地重新激活了循环素抑制的BCHE,这表明它们有可能作为通透中枢神经系统的抗剂.
- 基于白醇的化合物表现出增强的BCHE抑制和抗氧化特性.
结论:
- 结构多样化的异环化合物作为胆化酶联体具有显著的治疗潜力.
- 这些发现为开发用于阿尔茨海默病和化学战剂保护的多功能剂提供了基础.
- 这些化合物的进一步开发是有必要的,因为它们具有神经保护和抗毒剂的应用.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
647
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
647
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.4K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.4K
Cholinesterases: Distribution and Function
555
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
555
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.1K


